The founder and executive chairman of Bharat Biotech Dr. Krishna Ella, received the dean’s awards from Johns Hopkins Bloomberg School of Public Health for his outstanding leadership and contributions to public health at the convocation ceremony in Baltimore, Maryland.
The recognition highlights his groundbreaking efforts, significant impact, and commitment to creating a homegrown, inventive, and secure vaccine with a global public health focus. The top honour from the school is designated for exceptional public health professionals showcasing outstanding leadership in enhancing and protecting public health.
Dr. Ella expressed gratitude for the award, stating it as a global acknowledgment of India’s scientific prowess. He dedicated the medal to Bharat, recognizing its success in advancing science and research, the exceptional team of scientists, and the outcomes of their strong commitment to public welfare.
Dr. Ella’s achievements encompass the creation of vaccines and monoclonal antibodies, such as Covaxin, India’s homegrown Covid-19 vaccine, the pioneering rotavirus vaccine Rotavac, the first WHO prequalified Typhoid conjugate vaccine Typbar TCV, and the Japanese Encephalitis vaccine Jenvac.
